Disclaimer: This page is intended for Healthcare Professionals and other relevant decision makers in [country] only.
Information about the BIMERVAX® Covid-19 Vaccine (also known as PHH-1V).
Conditional marketing authorisation for [country] has been granted by the European Medicines Agency to be used for individuals 16 years of age and older.
Adverse events Reporting
For suspected adverse events, please contact your National Health Authority.
More information
For any information about this medicine including product quality complaint, please contact our Covid-19 vaccine dedicated Contact Center which is available 24 hours, 7 days a week:
Company information
17170 Amer (Girona)
Spain